Lung immune prognostic index (LIPI) as a prognostic factor in patients with extensive-stage small cell lung cancer treated with first-line chemoimmunotherapy.
Elena Herranz-BayoLuis Enrique Chara-VelardeJavier Cassinello-EspinosaVicente Gimeno-BallesterÁngel Artal-CortésAlba Moratiel PelliteroArancha Alcácera-LópezFátima Navarro-ExpósitoBlanca Riesco-MontesManuel Clemente-AndujarPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
In patients with ES-SCLC treated with chemoimmunotherapy, an intermediate and poor pretreatment LIPI score was associated with worse PFS and OS prognosis.